Education
About Us
Working with TipRanks
Follow Us
Microbix Biosystms J (TSE:MBX)
TSX:MBX
Total Valuation
Microbix Biosystms has a market cap or net worth of C$32.56M. The enterprise value is C$30.98M.
Market CapC$32.56M
Enterprise ValueC$30.98M
Share Statistics
Microbix Biosystms has 138,553,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding138,553,380
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Microbix Biosystms’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -4.41%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)-4.41%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee185.85K
Profits Per Employee-22.46K
Employee Count100
Asset Turnover0.50
Inventory Turnover0.95
Valuation Ratios
The current PE Ratio of Microbix Biosystms is ―. Microbix Biosystms’s PEG ratio is 0.10.
PE Ratio―
PS Ratio1.98
PB Ratio1.33
Price to Fair Value1.33
Price to FCF-42.02
Price to Operating Cash Flow-9.20
PEG Ratio0.10
Income Statement
In the last 12 months, Microbix Biosystms had revenue of 18.59M and earned -2.25M in profits. Earnings per share was -0.02.
Revenue18.59M
Gross Profit9.85M
Operating Income-1.58M
Pretax Income-2.30M
Net Income-2.25M
EBITDA428.23K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -3.48M and capital expenditures -764.61K, giving a free cash flow of -4.24M billion.
Operating Cash Flow-3.48M
Free Cash Flow-4.24M
Free Cash Flow per Share-0.03
Dividends & Yields
Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.25
52-Week Price Change-52.08%
50-Day Moving Average0.23
200-Day Moving Average0.27
Relative Strength Index (RSI)50.75
Average Volume (3m)57.61K
Important Dates
Microbix Biosystms upcoming earnings date is May 14, 2026, TBA (Confirmed).
Last Earnings DateFeb 12, 2026
Next Earnings DateMay 14, 2026
Ex-Dividend Date―
Financial Position
Microbix Biosystms as a current ratio of 8.48, with Debt / Equity ratio of 30.47%
Current Ratio8.48
Quick Ratio5.17
Debt to Market Cap0.15
Net Debt to EBITDA-12.47
Interest Coverage Ratio-1.66
Taxes
In the past 12 months, Microbix Biosystms has paid -55.73K in taxes.
Income Tax-55.73K
Effective Tax Rate0.02
Enterprise Valuation
Microbix Biosystms EV to EBITDA ratio is 73.65, with an EV/FCF ratio of -35.94.
EV to Sales1.70
EV to EBITDA73.65
EV to Free Cash Flow-35.94
EV to Operating Cash Flow-392.81
Balance Sheet
Microbix Biosystms has C$9.10M in cash and marketable securities with C$8.11M in debt, giving a net cash position of C$989.29K billion.
Cash & Marketable SecuritiesC$9.10M
Total DebtC$8.11M
Net CashC$989.29K
Net Cash Per Share<C$0.01
Tangible Book Value Per ShareC$0.17
Margins
Gross margin is 46.74%, with operating margin of -8.48%, and net profit margin of -12.08%.
Gross Margin46.74%
Operating Margin-8.48%
Pretax Margin-12.38%
Net Profit Margin-12.08%
EBITDA Margin2.30%
EBIT Margin-7.27%
Analyst Forecast
The average price target for Microbix Biosystms is C$0.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.50
Price Target Upside117.39% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-26.81%
EPS Growth Forecast-161.24%